Previous studies investigated the frequency of MGMT promoter hypermethylation in BTC [29, 30] and its role in tumor progression [31, 32] with inconclusive results, mostly due to the small sample size, the lack of clinical information, and the variability of assays used for testing this biomarker. Here, MGMT is linked to neoplasm.